Search results
Appearance
There is a page named "Anti-obesity drug" on Wikipedia
- genetic conditions that cause obesity. It is less effective and not approved for general obesity. Some weight loss drugs act on the neurotransmitters serotonin...53 KB (4,991 words) - 05:08, 21 July 2024
- Orlistat (redirect from Alli (drug))stability, orlistat was chosen over lipstatin for development as an anti-obesity drug. The effectiveness of orlistat in promoting weight loss is definite...39 KB (3,466 words) - 10:08, 22 May 2024
- Semaglutide (category Drugs with non-standard legal status)antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. It is a peptide similar...66 KB (5,434 words) - 17:03, 8 August 2024
- Naltrexone/bupropion (category Anti-obesity drugs)physical activity, as anti-obesity medication for the management of weight in adults with an initial body mass index (BMI) of: 30 kg/m2 (obese), or 27 kg/m2 to...21 KB (1,593 words) - 01:57, 16 July 2024
- Fenfluramine/phentermine (category Combination anti-obesity drugs)The drug combination fenfluramine/phentermine, usually called fen-phen, was an anti-obesity treatment in the early 1990s that utilized two anorectics...20 KB (2,185 words) - 07:38, 6 April 2024
- Sibutramine (category Withdrawn anti-obesity drugs)of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action". Obesity Reviews. 1 (2): 127–139. doi:10.1046/j.1467-789x...39 KB (3,518 words) - 09:36, 9 May 2024
- Rimonabant (category Withdrawn anti-obesity drugs)anti-obesity treatment for approval. The application was deemed not-approvable by FDA, and the company cancelled plans for a re-submission. The drug was...14 KB (1,176 words) - 20:07, 10 March 2024
- Cagrilintide/semaglutide (category Combination anti-obesity drugs)June 2023). "Approved Anti-Obesity Medications in 2022 KSSO Guidelines and the Promise of Phase 3 Clinical Trials: Anti-Obesity Drugs in the Sky and on the...6 KB (422 words) - 13:41, 6 August 2024
- Bariatric surgery (redirect from Obesity surgery)surgery) is a medical term for surgical procedures used to manage obesity and obesity-related conditions. Long term weight loss with bariatric surgery...67 KB (7,795 words) - 18:37, 6 August 2024
- Phenylpropanolamine (category Anti-obesity drugs)Tonkin AM, McNeil JJ (2006). "Safety of drug therapies used for weight loss and treatment of obesity". Drug Saf. 29 (4): 277–302. doi:10.2165/00002018-200629040-00001...51 KB (5,502 words) - 23:47, 3 August 2024
- Orforglipron (category Experimental anti-obesity drugs)1056/NEJMoa2302392. PMID 37351564. Sidik, Saima (2023). "Beyond Ozempic: brand-new obesity drugs will be cheaper and more effective". Nature. 619 (7968): 19. Bibcode:2023Natur...3 KB (184 words) - 13:53, 14 June 2024
- Rights to Alvogen in Korea for Anti-Obesity Drug". 6 September 2017. Letter, The Pharma. "Alvogen adds Qsymia to its anti-obesity portfolio in South Korea"...11 KB (914 words) - 20:13, 22 June 2024
- Phentermine/topiramate (category Anti-obesity drugs)under the brand name Qsymia, is a combination drug of phentermine and topiramate used to treat obesity. It is used together with dietary changes and exercise...10 KB (941 words) - 05:50, 2 July 2024
- Survodutide (category Experimental anti-obesity drugs)preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy". Molecular Metabolism. 66: 101633. doi:10.1016/j.molmet.2022...7 KB (207 words) - 18:46, 16 June 2024
- GLP-1 receptor agonist (redirect from GLP-1 drug)body weight, making them an effective treatment for obesity. Another class of anti-diabetes drugs, the DPP-4 inhibitors, work by reducing the breakdown...37 KB (3,890 words) - 03:08, 12 August 2024
- Phentermine (category Anti-obesity drugs)Diethylproprion: Sympathomimetic Drugs in the Management of Obesity". In Bray GA, Bouchard C (eds.). Handbook of Obesity - Volume 2 Clinical Applications...20 KB (1,714 words) - 14:14, 6 August 2024
- lifespan in healthy laboratory mice. Rimonabant (Acomplia) is an anti-obesity drug initially approved for use in the European Union but later withdrawn...23 KB (2,847 words) - 12:04, 25 March 2024
- Monlunabant (category Experimental anti-obesity drugs)metabolic syndrome. A randomized, placebo-controlled, double-blind phase 1b study". Diabetes, Obesity and Metabolism. doi:10.1111/dom.15353. PMID 37941317....5 KB (286 words) - 01:39, 16 August 2024
- 2,4-Dinitrophenol (category Withdrawn anti-obesity drugs)weight loss drug due to its dangerous side effects, its mechanism of action remains under investigation as a potential approach for treating obesity and non-alcoholic...35 KB (3,728 words) - 18:23, 1 August 2024
- Tesofensine (category Experimental anti-obesity drugs)reuptake inhibitor from the phenyltropane family of drugs, which is being developed for the treatment of obesity. Tesofensine was originally developed by a Danish...16 KB (1,763 words) - 20:54, 16 August 2024
- Willyard, “How anti-ageing drugs could boost COVID vaccines in older people”, Nature, (14 October 2020), 586, pp.352-354 Carolyn Bramante, an obesity researcher
- engaged in making or selling 'obesity cures,' and consists in the main of a list of supposed producers and selles of 'anti-fat remedies' compiled from the
- adrenaline and were used to treat narcolepsy during WWII and depression and obesity in the 50’s and 60’s Antacids - simple bases, such as metal oxides, hydroxides